A new phase 3 trial has launched for a novel treatment for select patients with essential thrombocythemia, a type of #MPN. curetoday.com/view/essential…

For patients with stage 3 #Melanoma, receiving postsurgical Keytruda did not noticeably affect health-related quality of life compared with placebo (inactive drug). curetoday.com/view/postsurgi…

Certain patients with KRAS-mutant #PancreaticCancer can now enroll in a nation-wide phase 2 trial evaluating a #CancerVaccine. curetoday.com/view/patients-…

After 15 years with chronic small lymphocytic lymphoma (#SLL), Linda has learned various lessons, from maintaining a positive mindset to balancing a healthy diet with exercise. curetoday.com/view/10-lesson…

CURE® welcomes readers to submit artwork for a chance to be featured in CURE®’s 2025 Calendar! Share your talents and submit your artwork now through October 3! Learn more here: ow.ly/anV050T7wQE

In the CURE® 2024 Hematology Special Issue, we focused on CAR-T cell therapy and the significant improvements that have been made since 2021 for patients with #BloodCancers. curetoday.com/view/moving-fo…

When Elouise Wrisper started experiencing persistent back pain, her doctor believed it was sciatica. But after a fall led to an MRI, something more was detected: #MultipleMyeloma. curetoday.com/view/speeding-…

There are many misconceptions about circulating tumor DNA (ctDNA) in the cancer space, so CURE® spoke with Ben Ho Park of Vanderbilt-Ingram Cancer Center to explain exactly what patients need to know. curetoday.com/view/what-pati…

After Debbie's daughter experienced #BreastCancer at age 27, Debbie's own relationship with her body changed. Watch:

As a #CancerSurvivor, Jeanne still feels like cancer swallows her up in darkness because she can't seem to see the ending, regardless of what doctors tell her. curetoday.com/view/good-to-g…

Every ache, every pain and every itch has a new meaning for CURE® blogger Debbie. After being a primary caregiver for her daughter during her #BreastCancer, she has become more aware of anything that may feel different. curetoday.com/view/how-my-da…

Nominations are OPEN for CURE and Oncology Nursing News' Extraordinary Healer 2025! Submit your nomination and celebrate our health care heroes! ow.ly/tYPj50T7zyY

For patients with oligometastatic #PancreaticCancer, a phase 2 study determined that metastasis-directed therapy plus chemotherapy showed some progression-free survival benefits, but more research is needed, said Dr. Ethan Ludmir MD of MD Anderson Cancer Center. curetoday.com/view/metastasi…

A new algorithm, Cyclone, is able to track immune responses and patterns in patients with advanced #Melanoma receiving an immunotherapy combination. #CancerNews curetoday.com/view/immunothe…

The #FDA is set to speed up the review for IBI363, a novel bispecific antibody, for patients with locally advanced or metastatic surgically unremovable melanoma (excluding choroidal melanoma). curetoday.com/view/fda-to-sp…

Oncology nurse Keri is a "true partner in the management and care of the whole patient," truly showcasing her ability to care for patients with cancer, even when there are some bumps in the road. curetoday.com/view/a-true-pa…

After #BreastCancer, Bonnie felt she was "granted a second chance at life," so she took this opportunity to do everything she wanted. But after pushing herself too hard, she realized that resting is a must. curetoday.com/view/rest-is-v…

In #myeloma, plasma cells transform into cancerous cells that crowd out the normal cells. These cells produce an abnormal antibody called M protein, a hallmark characteristic of myeloma. This #BloodCancerAwarenessMonth, learn about myeloma from @themmrf: ow.ly/frcQ50TgOAY

BREAKING: The #FDA approved Boruzu, an injection for patients with #MultipleMyeloma and mantle cell lymphoma. curetoday.com/view/boruzu-ap…

Do you or someone you know have kidney cancer? CURE® will be interviewing an expert to address all your questions about kidney cancer. Post your questions in the comments below and stay tuned for our expert's responses! #KidneyCancer #CancerAwareness #FAQ